Biography
Dr. Adam Carrico is a licensed, clinical health psychologist who is board certified in addiction psychology. He has received over $43 million in NIH funding as a principal investigator, published over 225 peer-reviewed publications (44% first or senior author), and has a Google Scholar h-index of 48 that is generally considered outstanding. Dr. Carrico's clinical and translational research program targets the intersection of methamphetamine use and HIV, particularly among sexual minority men (i.e., gay, bisexual, and other men who have sex with men). He led one of the first studies documenting the outcomes of substance use disorder treatment implemented from a harm reduction perspective, which was featured in the San Francisco Chronicle. Dr. Carrico's team was also the first demonstrate the efficacy of a behavioral intervention model for reducing HIV viral load and altering DNA methylation in leukocytes among people with HIV who use substances.
To date, Dr. Carrico has led 10 randomized controlled trials funded by the NIH to optimize the benefits of biomedical approaches to HIV prevention such as pre-exposure prophylaxis and HIV treatment as prevention. He also co-leads two remote US national cohort studies examining the biobehavioral pathways linking stimulant use with amplified risk of HIV acquisition and accelerated HIV pathogenesis.